Millions of healthcare and essential workers have worn N95 respirators or other medical masks to protect themselves over the course of the COVID-19 pandemic. …
UTRF in the News
UTRF, UTHSC, and Anviron Partner to Commercialize Novel Treatment for Pancreatic Cancer
A Mission for Making Good Medicine The University of Tennessee Research Foundation (UTRF), the University of Tennessee Health Science Center (UTHSC), and …
UTRF Licensee Announces Positive Phase 2 Clinical Results of VERU-111 for COVID-19
UTRF licensee Veru, Inc. announced today significant potential of VERU-111 in treating COVID-19, both as a broad-spectrum antiviral and an anti-inflammatory …